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groups regarding the change in FEV 1 (mean difference –0.8% 
predicted, 95% CI –4.4 to 2.9% predicted, p = 0.33), 6MWD 
(mean difference 12.2 m, 95% CI –37.4 to 12.2 m, p = 0.16), 
CRQ (mean difference in total score 0.2, 95% CI –0.1 to 0.4,
p = 0.11) and rMSSD (mean difference 2.2 ms, 95% CI –20.8
to 25.1 ms, p = 0.51).  Conclusions: In patients with COPD un-
dergoing a pulmonary rehabilitation program, controlled 
breathing using respiratory biofeedback has no effect on ex-
ercise capacity, pulmonary function, quality of life or cardiac 
autonomic function.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Expiratory flow limitation in patients with chronic 
obstructive pulmonary disease (COPD) results from pro-
gressive airway inflammation causing parenchymal de-
struction, mucosal oedema, airway remodelling, mu-
cous impaction and increased cholinergic airway smooth 
 Key Words 
 Chronic obstructive pulmonary disease   Controlled 
breathing   Respiratory biofeedback   Pulmonary 
rehabilitation   Diaphragmatic breathing   Pursed lips 
breathing  
 Abstract 
 Background: Conventional pulmonary rehabilitation pro-
grams improve exercise tolerance but have no effect on pul-
monary function in patients with chronic obstructive pulmo-
nary disease (COPD). The role of controlled breathing using 
respiratory biofeedback during rehabilitation of patients 
with COPD remains unclear.  Objectives: To compare the ef-
fects of a conventional 4-week pulmonary rehabilitation 
program with those of rehabilitation plus controlled breath-
ing interventions.  Methods: A randomized controlled trial 
was performed. Pulmonary function (FEV 1 ), exercise capacity 
(6-min walking distance, 6MWD), health-related quality of 
life (chronic respiratory questionnaire, CRQ) and cardiac au-
tonomic function (rMSSD) were evaluated.  Results: Forty 
COPD patients (mean  8 SD age 66.1  8 6.4, FEV 1 45.9  8 
17.4% predicted) were randomized to rehabilitation (n = 20) 
or rehabilitation plus controlled breathing (n = 20). There 
were no statistically significant differences between the two 
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muscle tone  [1] . Advanced COPD is associated with re-
duced exercise tolerance and daily physical activity re-
sulting in impaired health-related quality of life  [2] , high 
health care use  [3] and increased mortality  [4] . Further-
more, patients with advanced COPD have a pathological 
breathing pattern with enhanced intrathoracic pressure 
swings due to severe airway obstruction  [5] . Previous 
studies have shown that pulmonary rehabilitation pro-
grams improve exercise tolerance  [6–7] and peripheral 
muscle strength  [8] , reduce exacerbation rate  [9] and im-
prove health-related quality of life, but not pulmonary 
function in patients with COPD  [10–11] .
 Predominantly diaphragmatic breathing (DB),
pursed-lips breathing (PLB) and prolonged exhalation 
are the most commonly used controlled breathing tech-
niques and the use of each of these modalities has certain 
clinical benefits. PLB appears to be an effective way to 
decrease dyspnoea  [12] , improve walking distance  [13] 
and gas exchange  [14–15] . DB in patients with COPD has 
been associated with improvement in blood gases  [16] . 
However, the relative contribution of each of these mo-
dalities to the overall improvement of the patients is not 
clear. Previous studies assessing the effectiveness of con-
trolled breathing included small numbers of heteroge-
neous patients and lacked a control group  [15] . 
 To address the question whether controlled breathing 
improves outcome of rehabilitation in COPD patients, we 
performed a randomized controlled trial (RCT) using re-
spiratory feedback training (RBF) to assess the effects of a 
4-week rehabilitation program using outcome parameters 
including pulmonary function tests, cardiopulmonary ex-
ercise capacity, health-related quality of life and cardiac 
autonomic modulation. We hypothesized that COPD pa-
tients who undergo pulmonary rehabilitation plus con-
trolled breathing will benefit more than patients partici-
pating in conventional pulmonary rehabilitation classes. 
 Methods and Materials 
 Study Subjects 
 Patients with COPD referred to the Department of Respira-
tory Medicine, Ruhrlandklinik, University of Duisburg-Essen, 
Germany, between November 2008 and July 2009 were consid-
ered for participation in the study. Inclusion criteria were: clini-
cally stable disease (no changes in medication dosage or frequen-
cy of administration, no clinical signs or symptoms of acute ex-
acerbations and no hospital admissions in the preceding 6 weeks), 
age between 40 and 75 years, postbronchodilator FEV 1 of less than 
80% predicted and an FEV 1 /FVC ratio of less than 0.7, and a BMI 
of more than 18 and less than 25 kg/m 2 . We excluded patients with 
respiratory disorders other than COPD,   1-antitrypsin deficien-
cy, a history of significant inflammatory disease other than 
COPD, cardiac diseases such as heart failure, cardiac arrhythmia 
and/or coronary artery disease, patients with a history of lung 
surgery, patients with diagnosis of cancer and patients who were 
unable to walk. Patients with oral corticosteroids and/or vasoac-
tive medication at inclusion were also excluded from the study. 
Each participant signed and dated a written informed consent 
form prior to participation.
 The study was approved by the Research Ethics Committee of 
the Medical Faculty, University of Essen-Duisburg, Germany 
(No. 07-3524) and written informed consent was obtained from 
all patients.
 Study Design 
 We performed a RCT with sequential analysis of the clinical 
training effects; tests were performed prior to and following com-
pletion of cardiopulmonary exercise training. 
 Methods 
 Cardiopulmonary Exercise Training  
 Cardiopulmonary exercise training was performed according 
to published  guidelines  [17–19] . Participants attended the outpa-
tient clinic 3 times per week (1.5-hour sessions) for 3–4 weeks 
performing 10 sessions of physical training. The session included 
dynamic strength training for the following muscles: quadriceps 
femoris, hamstrings, triceps surae, pectoralis major, deltoid, latis-
simus dorsi and triceps brachi. The dynamic strength training 
exercises were performed while seated. Patients started at 70% of 
their initial 1-repetition maximum (1RM) and fulfilled 3 cycles of 
10 repetitions of isotonic muscle contractions  [17–19] with a rest-
ing period of 2 min between the series. 1RM is the maximum 
amount of weight one can lift during a single repetition of a given 
exercise.
 When the patients were able to perform 3 sets of 10 repetitions 
without any difficulty, effort was increased stepwise by 5% of the 
1RM. Cardiopulmonary endurance training was performed on a 
cycle ergometer, using stepping exercises and arm cranking  [17–
19] . The initial intensity for cycling was set at 30% peak workload 
for 20 min. Increases in workload were based upon symptom 
scores.
 Controlled Breathing Training 
 Twenty patients allocated to the RBF group participated in 10 
supplemental 30-min sessions of controlled breathing using tech-
niques of respiratory biofeedback training and were instructed on 
its performance during the first training session  [20–22] . The re-
spiratory biofeedback training system visually displays the de-
sired respiratory pattern: the patients were trained to voluntarily 
improve their breathing pattern at rest for 10 min while seated 
with instructions for daily home practice. Furthermore, the pa-
tients were trained to improve their breathing pattern during the 
20 min of cardiopulmonary endurance training which was per-
formed on a cycle ergometer.
 The patients were trained to modify four respiratory charac-
teristics: rapid shallow breathing (increased respiratory rate and 
low tidal volume), breath-to-breath irregularity in rate and depth 
and predominant thoracic breathing. DB was performed as de-
scribed by Gosselink  [23, 24] by ‘facilitating outward motion of 
the abdominal wall while reducing upper rib cage motion during 
inspiration’. 
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 Dynamic hyperinflation occurs when inspiration commences 
prior to completion of the preceding exhalation so that air is 
trapped ‘upstream’ at the small bronchiolar and alveolar levels. To 
reduce dynamic hyperinflation, the patients were encouraged by 
prolonging the expiration prior to the initiation of the next breath 
while using PLB.
 The breathing pattern was monitored by respiration sensors 
that measure the patient’s breathing rhythm at both umbilical and 
abdominal level. The respiration sensors were connected to an 
amplifier (Nexus-10 TM medical device class IIa; TMS Internation-
al BV, Enschede, The Netherlands) that converts the electrical im-
pulses into acoustical and visual outputs. BioTrace+ software was 
used for physiological monitoring and signal processing. 
 The RBF training works with simple acoustic tones and visual 
graphic signals in order to inform the patient precisely about their 
actual breathing pattern. Both signals were simultaneously used 
as a feedback for the patient via an earphone and an overhead 
screen. Both signals increase and decrease in volume and inten-
sity as the patient breathes in and out. 
 Measurements 
 Pulmonary Function 
 Spirometry, whole body plethysmography and diffusion ca-
pacity measurements were performed according to the American 
Thoracic Society and the European Respiratory Society guide-
lines with a commercially available system (Body 500 TM ; ZAN, 
Oberthulba, Germany)  [25] . Postbronchodilator spirometry was 
performed on the same day as the exercise tests (6-min walk test, 
6MWT). Maximal inspiratory mouth occlusion pressure after 
100 ms was measured as previously described  [26] .
 Six-Minute Walk Test 
 All patients performed the 6MWT following pulmonary func-
tion testing. 6MWT distance was measured according to the 
guidelines of the American Thoracic Society  [27–28] . Oxygen sat-
uration and pulse rate were recorded using a standard pulse ox-
imeter (Nexus-10 TM medical device class IIa; TMS International 
BV). Additionally, scored sensations of breathlessness and leg fa-
tigue were assessed using a modified Borg scale  [29] . The 6MWT 
was performed on a 30-meter indoor track by an experienced in-
vestigator using standardized encouragement strategy  [30] , and 
the results were recorded in absolute values and in percent pre-
dicted  [27] . To control for any learning effect, all patients per-
formed two 6MWTs on two separate days, and the results of the 
second test were used for analysis. 
 Health-Related Quality of Life 
 The Chronic Respiratory Questionnaire (CRQ) is an estab-
lished measure of health status for chronic obstructive pulmo-
nary disease  [31–32] . Previous studies have shown that an im-
provement in score in any domain of the CRQ of  6 0.5 represents 
the minimal clinically important difference that is noticeable to 
patients  [31] , changes in any domain of the CRQ  1 1.0 represent 
moderate improvements and changes in any domain of the CRQ 
 1 1.5 represent large improvements in health-related quality of
life  [32] . 
 Cardiac Autonomic Function 
 Analysis of heart rate variability (HRV) is a powerful method 
to assess the autonomic nervous system. HRV is a physiological 
phenomenon describing the variation of the time interval be-
tween heart beats which is related to the relative acitivity of the 
sympathetic and parasympathetic nervous system. A reduced 
HRV implies an impaired ability of the heart to alter its own beat 
frequency and therefore a pathological condition of the cardio-
vascular system  [33, 37–39] . Cardiovascular autonomic function 
was assessed by measuring the standard time and frequency do-
main measures of HRV from 5 min of the R-R interval recordings 
in the ECG, with the patients in seated. HRV was obtained via 
3-channel ECG recording (Nexus-10 TM medical device class IIa; 
TMS International BV) as recommended by the Task Force of the 
European Society of Cardiology and the North American Society 
of Pacing and Electrophysiology  [33] . To eliminate artefacts an 
automatic filter excluded RR sequence differing by more than 
30% from the previous interval  [33] . Time domain measures of 
HRV were calculated from the R-R interval tachograms. The fol-
lowing time domain measures of HRV were calculated: mean R-R 
(NN mean) in milliseconds, the standard deviation of R-R inter-
vals (SDNN) in milliseconds and the root mean square successive 
difference of R-R intervals (rMSSD) in milliseconds.
 The following standard frequency domain measures of HRV 
were computed: high-frequency spectral power (HF power, the 
density of the beat-to-beat oscillation in the R-R interval of HRV 
in the high-frequency band; HF = 0.15–0.4 Hz), low-frequency 
spectral power (LF power, the density of the beat-to-beat oscilla-
tion in the R-R interval of HRV in the low-frequency band; LF = 
0.04–0.15 Hz), the ratio of LF to HF power (LF/HF ratio). LF/HF 
ratio has been described as a marker of sympathetic to parasym-
pathetic balance  [34–36] . Spectral components were expressed 
both as absolute values in milliseconds and as normalized units. 
To reflect the degree of parasympathetic modulation of heart
rate, we used both HF power (%) and rMSSD (ms)  [33, 37–39] .
 Data Analysis 
 We performed an RCT (ClinicalTrials.gov identifier: 
NCT01175265) with sequential analysis of the clinical training
effects; tests were performed prior to and following completion
of cardiopulmonary exercise training. Twenty patients were as-
signed to receive 10 sessions of 1.5 h of physical exercise training 
plus additional ten 30-min RBF sessions (RBF group). In the oth-
er group, 20 patients were assigned to receive ten 1.5-hour sessions 
of physical exercise training only (control group) over 4 weeks. 
The technicians, who performed the pulmonary function tests 
and 6MWTs, were blinded for the randomization. In order to con-
trol for any residual learning effect, the patients performed two 
6MWTs at baseline on separate days; the second 6MWT was used 
for analysis. 
 Data on pulmonary function, cardiopulmonary exercise ca-
pacity, health-related quality of life and cardiac autonomic modu-
lation were collected prior to and following completion of 4 weeks 
of pulmonary rehabilitation. 
 A statistical software package was used for statistical analysis 
(SPSS for Windows, version 11.0; SPSS Inc., Chicago, Ill., USA). 
Descriptive data for continuous variables are expressed as mean 
 8 SD. Effects of pulmonary rehabilitation were evaluated by 
within-group comparisons of changes over 4 weeks, using paired 
Student’s t  tests. Differences in changes from baseline to follow-up 
between the two groups were compared using unpaired Student’s 
t tests. A p value of  ! 0.05 was considered to be significant.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
6/
22
/2
01
6 
5:
53
:1
9 
PM
 van Gestel  /Kohler  /Steier  /Teschler  /Russi  /
Teschler  
Respiration 2012;83:115–124 118
 Results 
 Patients 
 Sixty-three patients with COPD (GOLD class I–IV) 
were evaluated for study participation. Forty-three pa-
tients were eligible for the study and agreed to participate. 
Twenty-two patients were randomized to the RBF group 
and 21 to the control group. Three patients withdrew 
from the study due to an acute COPD exacerbation dur-
ing the training period.
 Baseline anthropometrical characteristics and pulmo-
nary function data of the 40 patients (23 females) with 
COPD are presented in  table 1 . Twenty-two patients had 
mild to moderate disease (GOLD I n = 4; GOLD II n = 
18), and 18 patients had severe or very severe COPD 
(GOLD III n = 16; GOLD IV n = 2). There were no sig-
nificant differences in the baseline anthropometrical 
characteristics and pulmonary function test results be-
tween the group receiving RBF and the control group.
 Changes in Pulmonary Function, Cardiopulmonary 
Exercise Capacity and Health-Related Quality of Life 
 Between-group comparisons of changes in pulmonary 
function, health-related quality of life and cardiopulmo-
nary exercise capacity over the 4 weeks of pulmonary re-
habilitation are shown in  table 2 . There was no change in 
lung function test results during the 4-week program in 
any of the groups, and the groups did not differ ( fig. 1 ). 
 Cardiopulmonary exercise capacity (6MWD) over the 
4 weeks of pulmonary rehabilitation showed no signifi-
cant differences between the groups ( fig.  2 ). Within-
group comparison for both study groups revealed a sig-
nificant improvement in exercise capacity over the 4 
weeks of pulmonary rehabilitation ( fig.  2 ): the 6-min 
walking distance increased in both groups [RBF group: 
  6MWD = +23.63 (30.70) m, p = 0.002 * * vs. control 
group:   6MWD = +36.21 (43.54) m, p = 0.0005 * * ]. 
 No significant differences were found in the quality of 
life between the two groups ( fig. 3 ). Within-group com-
parisons for both study groups showed highly significant 
improvements in health-related quality of life after 4 
weeks of pulmonary rehabilitation [RBF group:   CRQ 
score = +0.64 (0.85), p  ! 0.001 * * vs. control group:   CRQ 
score = +0.48 (0.85), p  ! 0.001 * * ].
 Changes in Cardiac Autonomic Function 
 Between-group statistical comparisons of improve-
ments in time and frequency domain measures of para-
sympathetic-induced HRV are shown in  table 3 . No sig-
nificant differences between changes in the mean values 
of R-R interval and R-R interval variability were found 
between both groups. 
Table 1.  Anthropometric and pulmonary function data
Variable RBF group (n = 20) Control group (n = 20) p value
Age, years 66.385.6 66.087.4 0.52
Height, cm 169.789.5 168.687.5 0.29
Weight, kg 75.4816.5 71.6816.0 0.21
BMI 25.983.6 24.983.4 0.19
Gender, female/male 11/9 12/8 0.4
FEV1, l 1.2880.62 1.1480.49 0.22
FEV1, % predicted 47.02819.90 44.31817.31 0.29
FEV1/IVC 46.71814.31 42.61814.41 0.21
TLC, l 6.3881.48 6.4381.22 0.49
TLC, % predicted 107.58828.87 114.39819.14 0.22
RV/TLC, ratio 55.32813.51 58.4788.69 0.24
RV/TLC, % predicted 136.74835.91 143.58825.62 0.31
P01max, cm H2O 0.4380.18 0.4380.15 0.48
P01max, cm H2O % predicted 210.21892.24 218.44869.22 0.42
DLCO, ml/min/mm Hg 4.8982.16 4.3281.59 0.22
DLCO, % predicted 58.21823.52 53.41817.01 0.31
D ata are presented as means 8 SD where applicable. IVC = Inspiratory vital capacity; RV = residual volume; 
P01max = maximal mouth occlusion pressure at 0.1 s; DLCO = diffusion capacity for carbon monoxide.
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 Within-group comparisons analyses showed improve-
ments in the measurements of parasympathetic-in-
duced HRV in both time and frequency domains ( table 3 ; 
 fig. 4 ). However, compared to baseline, no significant dif-
ferences in any measurement of parasympathetic-in-
duced HRV in frequency domains were found over the 4 
weeks of pulmonary rehabilitation in the control group. 
Only the RBF group showed significant improvements in 
resting SDNN (ms) over the 4 weeks of pulmonary reha-
bilitation; SDNN increased from 32.0 (23.7) ms to 48.0 
(52.8) ms (p = 0.037 * ).
 Discussion 
 This is the first RCT comparing the effects of a 4-week 
rehabilitation program including controlled breathing 
using respiratory biofeedback to a 4-week rehabilitation 
program alone on pulmonary function (pulmonary 
function tests), cardiopulmonary exercise capacity, 
health-related quality of life and cardiac autonomic mod-
ulation. The initial hypothesis is not corroborated by the 
present observations; controlled breathing using a tech-
nique of RBF does not produce additional benefits com-
Table 2.  Changes of pulmonary function, cardiopulmonary exercise capacity and health-related quality of life
Variable RBF group 
(n = 20)
Control group 
(n = 20)
Mean 
difference
95% CI of 
the difference
p 
value
Pulmonary function
FEV1, l –0.2180.15 –0.0180.12 –0.01 –0.10 to 0.08 0.41
FEV1, % predicted –1.4285.61 –0.6385.44 –0.79 –4.43 to 2.85 0.33
FEV1/IVC –2.0088.67 1.1186.21 0.11 –8.07 to 1.86 0.11
FRC, l 0.1680.73 0.0180.98 0.15 –0.43 to 0.73 0.30
FRC, % predicted 4.67824.75 1.32832.09 3.35 –15.85 to 22.56 0.36
RV/TLC 0.5688.16 1.0087.20 –0.44 –5.57 to 4.68 0.43
RV/TLC, % predicted 1.50820.03 2.11817.20 –0.61 –13.05 to 11.84 0.45
P01max, cm H2O –0.4682.15 0.4381.64 –0.89 –2.15 to 0.37 0.08
P01max, cm H2O % predicted –13.47846.83 –9.89838.97 –23.37 13.97 to 4.98 0.52
DLCO, ml/min/mm Hg –0.2580.54 –0.1080.73 –0.15 –0.60 to 0.30 0.25
DLCO, % predicted –3.1287.04 –1.1788.80 –1.95 –7.45 to 3.55 0.24
IVC, l 0.0180.28 –0.1380.30 0.14 –0.06 to 0.33 0.08
IVC, % predicted 0.0089.78 –4.00810.42 4.00 –2.65 to 10.65 0.12
TLC, l 0.0480.73 –0.0380.96 0.07 –0.50 to 0.64 0.40
TLC, % predicted –0.06813.24 0.05816.52 –0.11 –10.08 to 9.92 0.49
Cardiopulmonary exercise capacity
6MWD, m 23.63830.70 36.21843.54 12.22 –37.37 to 12.21 0.16
SpO2 rest, % 0.3781.74 –1.0081.73 1.37 0.23 to 2.51 0.20
SpO2 after, % 0.7982.84 0.3783.37 0.42 –1.63 to 2.47 0.34
Dyspnoea rest, 0–10 0.280.9 –0.381.0 0.5 –0.2 to 1.1 0.08
Dyspnoea after, 0–10 –0.181.0 0.381.7 –0.3 –1.3 to 0.6 0.23
Fatigue rest, 0–10 –0.180.9 0.380.9 –0.4 –1.0 to 0.2 0.11
Fatigue after, 0–10 –0.481.6 –0.181.7 –0.3 –1.4 to 0.7 0.26
Health-related quality of life
Dyspnoea 0.8880.74 0.5781.01 0.28 –0.26 to 0.87 0.14
Fatigue 0.5780.90 0.2680.74 0.32 –0.21 to 0.84 0.12
Emotional function 0.5280.81 0.6580.70 –0.13 –0.61 to 0.35 0.29
Mastery 0.6280.97 0.4580.90 0.17 –0.43 to 0.77 0.30
Total score 0.6480.85 0.4880.85 0.17 –0.10 to 0.43 0.11
D ata are presented as means 8 SD. Changes for each group over 4-week period of pulmonary rehabilitation. IVC = Inspiratory 
vital capacity; TLC = total lung capacity; RV = residual volume; P0.1 = mouth occlusion pressure 0.1 s after the beginning of inspira-
tion; DLCO = carbon monoxide transfer coefficient; SPO2 rest = peripheral oxygen saturation measured at rest; SPO2 after = SPO2 
peripheral oxygen saturation measured after 6MWT.
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pared to conventional pulmonary rehabilitation pro-
grams.
 Pulmonary Function, Health-Related Quality of Life 
and Cardiopulmonary Exercise Capacity 
 It has been established that pulmonary rehabilitation 
in patients with COPD results in increased exercise toler-
ance, peripheral muscle force and health-related quality 
of life without any effects on pulmonary function or arte-
rial blood gas levels  [40–43] . Accordingly, we found sig-
nificant improvements in both health-related quality of 
live (Chronic Respiratory Questionnaire) and exercise 
tolerance (6MWD) but not on any pulmonary function 
parameters reflecting airflow limitation, inspiratory lung 
capacity or lung hyperinflation over the 4 weeks of pul-
monary rehabilitation. 
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 Fig. 1. There was no statistically signifi-
cant difference in the change of FEV 1 be-
tween the RBF group (left) and the control 
group (right) after the 4 weeks of pulmo-
nary rehabilitation.  
 Fig. 2. There was no statistically signifi-
cant difference in the change of cardiopul-
monary exercise capacity as assessed by 
the 6MWD between the RBF group (left) 
and the control group (right) after the 4 
weeks of pulmonary rehabilitation. With-
in both groups, there was a statistically sig-
nificant improvement in 6MWD after pul-
monary rehabilitation. ** = highly signifi-
cant.  
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 Reviewing of the literature on controlled breathing 
techniques, such as DB, PLB and prolonged exhalation in 
patients with COPD, reveals that the use of each of these 
modalities has certain clinical benefits: PLB appears to be 
an effective way to decrease dyspnoea  [12–13] , improve 
the walking distance in the 6MWT  [13] and improve gas 
exchange  [15, 44] . Furthermore, PLB has been shown to 
provide sustained improvement in exertional dyspnoea 
and physical performance  [45] . DB in patients with COPD 
is associated with improvement of blood gases at the ex-
pense of a greater inspiratory muscle loading  [16, 23, 46] . 
Several studies have demonstrated that COPD patients 
are able to voluntarily change their breathing pattern to 
more abdominal movement and less thoracic excursion 
 [24, 47–48] ; however, no changes in ventilation distribu-
tion could be observed  [48] . 
p = 0.11
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 Fig. 3. There was no statistically signifi-
cant difference in the change of health-re-
lated quality of life as assessed by the CRQ 
between the RBF group (left) and the con-
trol group (right). A statistically signifi-
cant improvement in health-related qual-
ity of life was observed in both groups after 
4 weeks. ** = highly significant.  
p = 0.51
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 Fig. 4. There was no statistically signifi-
cant difference in the change of cardiac au-
tonomic function as assessed by rMSSD 
between the RBF group (left) and the con-
trol group (right). 
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 However, contradictory evidence exists about the ef-
fectiveness of controlled breathing techniques: Garrod 
 [49] found that pursed lips breathing did not improve 
walking distance in nonspontaneous pursed-lips breath-
ing COPD patients and Gosselink et al.  [24] found that 
DB was associated with a decrease in mechanical effi-
ciency in comparison with natural breathing in patients 
with COPD. Further analysis of the literature to date does 
not support the use of DB to improve ventilation, gas ex-
change, or the work of breathing in patients with COPD 
 [57–59] . In summary, DB seems to have negative and pos-
itive effects, but the latter appears to be caused by simply 
slowing the respiratory rate  [15] . 
 To date, no trials have been published that investigated 
patients’ ability to train these breathing techniques all to-
gether and evaluate their overall effects over a prolonged 
period of time. In this study, no additional benefits from 
controlled breathing interventions in pulmonary func-
tion, health-related quality of life and cardiopulmonary 
exercise capacity were observed over the 4 weeks of pul-
monary rehabilitation. 
 Cardiac Autonomic Function  
 Giardino et al.  [22] found that after 10 weeks of con-
trolled breathing, patients with COPD showed statisti-
cally and clinically significant improvements in para-
sympathetic tone  [22] . These results suggest that breath-
ing interventions per se can produce long-term changes 
in multiple organ systems that are affected by autonomic 
control. Although the improvement in parasympathetic-
induced HRV in time domain of the RBF group in this 
study was significant, there seems to be no significant ad-
ditional benefit from controlled breathing on parasym-
pathetic tone over the 4 weeks of pulmonary rehabilita-
tion. 
 Previous studies have established that patients with 
COPD have predominant sympathetic tone at rest, as as-
sessed by increased resting heart rate and reduced HRV 
 [50] , and that the presence of cardiac autonomic dysfunc-
tion is generally associated with worse prognosis  [51–53] . 
Predominant resting sympathetic tone in COPD may 
even have negative consequences on inflammation, ca-
chexia and skeletal muscle dysfunction  [54] . In accor-
dance with this, we found that mean resting HR was el-
evated [89.1 (20.7) beats/min] and HRV was reduced 
[34.50 (31.10) ms] compared to published control data 
 [55–56] , underlining increased sympathetic tone at rest 
in the patients of this study.  
 HF power, SDNN and rMSSD are widely accepted to 
reflect the degree of parasympathetic induced modula-
tion of heart rate  [33, 37–38] . Interestingly we found that, 
after 4 weeks of intensive cardio-pulmonary exercise 
training, all variables reflecting parasympathetic tone in-
creased. The increase in SDNN of the RBF group was 
statistically significant. These results show that cardiac 
autonomic dysfunction can be positively influenced by 
intensive physical exercise training in patients with 
COPD. However, the pathophysiological mechanism un-
derlying the substantially enhanced resting parasympa-
thetic tone due to cardiopulmonary exercise training in 
patients with COPD remains unclear. 
 Limitations of the Study 
 It should be stressed that a number of patients found 
it difficult to change their breathing pattern during exer-
cise performance. The controlled breathing techniques 
Table 3.  Changes of R-R interval and R-R interval variability
Variable RBF group
(n = 20)
Control group
(n = 20)
Mean
difference
95% CI of
the difference
p 
value
NNmean, ms 10.268159.81 1.008133.24 9.23 –98.55 to 117.07 0.43
SDNN, ms 23.79844.24 12.80829.10 10.98 –17.35 to 39.32 0.22
rMSSD, ms 9.2835.1 8.1824.1 2.15 –20.77 to 25.06 0.51
LF/HF ratio 0.4782.42 –0.2082.57 0.67 –1.17 to 2.51 0.23
LF power, % –3.43816.10 1.47813.28 –4.90 –15.71 to 5.91 0.18
HF power, % 2.56823.77 1.41817.20 1.15 –14.02 to 16.31 0.44
D ata are presented as means 8 SD. Changes for each group over 4 weeks period of pulmonary rehabilita-
tion. NNmean = Mean; R-Rs = interbeat intervals; SDNN = SD of R-Rs; rMSSD = the root mean square succes-
sive difference of R-Rs.
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used in this study might be more beneficial if trained sep-
arately. It could be possible that pursed-lips breathing 
might be counteracted by those which might increase the 
work of breathing, such as deep DB  [24] . In addition, a 
number of patients found it difficult to change their 
breathing pattern during exercise performance and thus 
the controlled breathing techniques used in this study 
may be more effective if trained separately rather than in 
combination. Furthermore, we cannot exclude that con-
trolled breathing has some long-term effects. As rehabil-
itation is a relatively powerful intervention, it is difficult 
to secure improvements over and above those observed 
by rehabilitation alone. Some clinically relevant param-
eters were not assessed, that is, tidal volume, inspiration 
time/expiration time ratio and dynamic hyperinflation 
during exercise; thus we cannot exclude that controlled 
breathing has a positive effect on hyperinflation. Future 
studies should assess the effects of controlled breathing 
on dynamic hyperinflation and assess the long-term ef-
fects of controlled breathing. Long-term effects of con-
trolled breathing might be helpful to develop appropriate 
therapeutic strategies and to improve long-term thera-
peutic management in COPD.
 The number of patients included in our study was rel-
atively small (n = 40). However, the 95% confidence inter-
vals of the difference in   FEV 1 between the two groups 
were –100 to 80 ml, thus we have excluded a significantly 
larger   FEV 1 in the RBF group of more than 80 ml which 
is within the range of the minimal clinical importance. 
Similarly, the 95% confidence intervals of the difference 
in   6MWD between the two groups were –37 to 12 m, 
thus we have excluded a significantly larger   6MWD in 
the RBF group of more than 12 m, again well within the 
range of the minimal clinical importance. 
 Conclusions 
 The initial hypothesis is not corroborated by the pres-
ent observations that controlled breathing sessions using 
a technique of RBF has any influence on pulmonary 
function, cardiopulmonary exercise capacity, health-re-
lated quality of life and cardiac autonomic function. The 
improvements on resting HRV observed in both groups 
show that cardiac autonomic dysfunction can be posi-
tively influenced by 4 weeks of intensive physical exercise 
training in patients with COPD. 
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